Objectives: To characterize interstitial cystitis pathology based on the expression profile of urothelial tissue-specific master transcription factors. Methods: Bladder carcinoma cell lines derived from the urothelial stem cells (epithelial or mesenchymal) were used to identify candidate urothelial master transcription factors. Gene expression was measured with quantitative reverse transcription polymerase chain reaction. From the initial screening of 170 transcription factors (human homologs of Drosophila segmentation genes and known master transcription factors from a database), 28 transcription factors were selected. Subsequently, messenger ribonucleic acid from bladder biopsies of interstitial cystitis patients was purified, and gene expression levels of known urothelial marker genes and candidate master transcription factors were measured. Multivariate expression data were analyzed with SPSS software. Results: Factor analysis decomposed the expression profile into four axes: principal axis 1 included retinoic acid receptors and 17 candidate master transcription factors. Principal axis 2 included KRT5 and five candidates. Principal axis 3 included transcription factor TP63 and two candidates. Principal axis 4 included SHH and two candidates. Principal component analysis segregated biopsies from Hunner's lesion in the principal component 1 (retinoic acid)/principal component 2 (SOX13)/principal component 3 (TP63) space. Conclusions: Urothelial master transcription factors could serve as novel diagnostic markers and potentially explain the molecular pathology of interstitial cystitis.
Introduction
IC is diagnosed by three requisites: symptoms (hypersensitivity, urinary frequency, bladder discomfort and pain), cystoscopic findings (Hunner's lesion as "ulcerative" or bladder glomerulation after hydrodistension as "non-ulcerative") and exclusion of confusable diseases. Hunner's lesion is observed as a circumscript, reddish mucosal spot with small vessels radiating towards a central scar, with a fibrin deposit or coagulum attached to this area. This site ruptures with increasing bladder distension, with petechial oozing of the bladder from the lesion and the mucosal margins in a waterfall manner.
1,2 Inflammatory collapse of umbrella cells is a major burden, but the pathology of IC remains elusive. [3] [4] [5] [6] Currently, there is no curative or satisfactory treatment for IC. Therefore, elucidation of IC pathology is critical to improve diagnosis and radical treatment. 1, 7 Recently, genome scientists have been keen to characterize master TFs for human development and disease. 8 -10 Master TFs control a battery of target genes critical for cellular identities and are themselves under feed-forward regulation by their own super enhancers. [8] [9] [10] Thus, identification of master TFs represents a novel molecular approach to understand human development and diseases. In the present study, we sought to characterize IC pathology based on gene expression profiles of urothelial master TFs. First, we screened candidate master TFs to understand the crucial transcription cascades in patients' urothelium. Second, we investigated expression profiles of known urothelial marker genes and candidate master TFs in bladder biopsies of IC patients. Multivariate analysis decomposed four principal factors that reflect urothelial development and regeneration. We found that biopsies from Hunner's lesion show characteristic "decreased progenitors and higher RA signaling."
Methods

Patients and biospecimens
The present study was approved by the institutional review board of Dokkyo Medical University Hospital (ID: 27023), on the basis of the ethical guidelines. Patients who were diagnosed as having IC at Dokkyo Medical University Hospital, Mibu, Tochigi, Japan, agreed to donate their bladder biopsies for research purposes.
Punch biopsy protocol
The sampling (punch biopsy) was carried out endoscopically from the Hunner's lesion, trigonal region and other parts of the bladder before the bladder hydrodistension. The size of the specimens was approximately 1-2 mm. If the patient did not have a Hunner's lesion, the urothelium with or without glomerulation during the bladder hydrodistension was sampled. However, punch biopsy from the bladder dome was avoided because of the high risk of bladder rupture.
Cell culture
We used bladder carcinoma cell lines that did or did not retain urothelial characteristics as initial screening material. BOY-12E (RCB2627), JMSU1 (RCB2227), T24 (RCB0431) and 5637 (RCB1191) cell lines were purchased from RIKEN Bio-resource Center (Tsukuba, Japan). HuB6 (named after human bladder) and HuB15 transitional carcinoma cell lines were established in our university hospital and described elsewhere. 11 We classified these cell lines into either epithelial (E) or mesenchymal (M) type, according to E-cadherin (a pan-epithelial marker) synthesis (Fig. S1a) . 5637, HuB6 and HuB15 synthesized abundant E-cadherin, and were grouped into the E-type, whereas BOY-12E, JMSU1 and T24 were grouped into the M-type (Fig. S1a) . E-type cell lines concomitantly synthesized transcription factor TP63, a master regulator of stratified epithelium (Fig. S1a) . 12, 13 In general, bladder carcinoma is a tumor derived from urothelial stem cells, 14 and several TFs in bladder diseases, such as c-Jun and E2F-1, have been investigated in previous studies. 15, 16 Importantly, bladder carcinoma frequently show a mesenchymal phenotype through epithelial-to-mesenchymal transition. For example, a well-established cell line T24 is known for mesenchymal characteristics through epithelial-to-mesenchymal transition. 17 We hypothesized that the two contrasting behaviors (i.e. E-or M-type) could be exploited for screening of candidate urothelial master TFs (see below). The four purchased cell lines were cultured under supplier-recommended conditions (for details, visit http://cell.brc.riken.jp/ en/). HuB6 and HuB15 were cultured using Dulbecco's Modified Eagle Medium (Wako, Osaka, Japan) supplemented with 5% fetal bovine serum (Gibco, Waltham, MA, USA).
Protein extraction and immunoblotting
Bladder cancer cell lines were fixed with 10% trichloroacetic acid (Wako), and whole-cell proteins were dissolved with solubilizing reagent (7 mol/L urea, 2 mol/L thiourea, 2% Triton X-100; Wako). The entangled genomic DNA was sheared by sonication for 20 min. The protein concentration was measured using Bradford Protein Assay (Bio-Rad, Hercules, CA, USA). Procedures for immunoblotting have been described elsewhere. 18 Primary antibodies used in the present study were as follows: E-cadherin antibody (#610181) was purchased from BD Transduction Laboratories (Franklin Lakes, NJ, USA). TP63 (#13109), SHH (#2207) and GAPDH (#5174) were from Cell Signaling Technologies (Danvers, MA, USA). Representative data are shown in Figure S1a ; experiments were repeated at least twice at different passage points.
Strategy for master TF screening
The strategy to identify candidate urothelial master TFs is as follows. Master TFs are known to have several characteristics including: (i) controlling a battery of target genes critical for lineage determination and cellular identities; (ii) controlling its own gene expression through auto-feedback super enhancers; and as a result, (iii) maintaining exceptionally high expression levels of their own coding genes. 8 We exploited the third characteristic in our screening criteria because of its accessibility. When the mRNA expression level of its coding gene was higher in E-type than in M-type cell lines, the TF was defined as a candidate (Fig. S1b) . RA is a known chemical to induce urothelial cell differentiation, and we added ATRA (Wako) treated E-type cells to our screening materials. 19 We used different concentrations and durations of ATRA because each cell line has different IC50 against ATRA (data not shown). The condition of ATRA treatment was as follows: 5637 (20 lmol/ L, 4 days), HuB6 (5 lmol/L, 5 days) and HuB15 (2.5 lmol/L, 6 days). We investigated three groups of TFs for the screening (Fig. S1b) . The first group (85 genes) belongs to evolutionary conserved homologs of Drosophila segmentation genes (Caudal, Bicoid, Hunchback, Kr€ uppel, Tailless, Even skipped, Hairy, Odd skipped, Paired, Runt, Fushitarazu, Sloppy paired, Odd paired and Engrailed). The second group (33 genes) belongs to master TFs identified from bladder tissue (UCSD_Bladder). 9 The third group (52 genes) belongs to master TFs from biopsies of colon crypts or cultured mammary epithelial cells (HMEC). 9 We prioritized the 170 genes because master TFs are developmental regulators evolutionally conserved. From the initial screening of 170 candidate TFs, 28 TFs were selected based on the following criteria: mRNA expression of each coding gene was higher in the epithelial (E) type than in the mesenchymal (M) type of bladder carcinoma cell lines (Figs S1,S2). TP63 and FOXA1 served as positive controls (Fig. S2 ).
Quantitative RT-PCR
Total RNA was purified using RNAiso Plus (Takara, Osaka, Japan). Reverse transcription was carried out using PrimeScript with gDNA Eraser (Takara). Quantification of the copy number of each mRNA was carried out using QuantStudio3 Real-Time PCR System (Applied Biosystems, Waltham, MA, USA) and the Taqman method. Data were calculated using the DCT method. We used the DCT parameter for statistical analysis because mRNA expression follows a log-normal distribution, whereas DCT follows normal distribution. Each gene expression is represented as log scale in Tables S3 and  S4 , where the CT value was normalized by either 18S rRNA or CDH1 (E-cadherin). A gene-specific fluorescent probe was designed using a web-based program (https://qpcr.probefinde r.com/organism.jsp). Table S1 shows the primer sequences and corresponding fluorescent probes. Gene-specific Taqman probes were purchased from Life Technologies (Waltham, MA, USA; for Cat#, see Table S2 ). For PCR, Thunderbird Probe qPCR mix (Toyobo, Osaka, Japan) was used, and the PCR conditions consisted of 40 cycles of two steps (95°C for 15 s and 60°C for 50 s).
Statistical analysis
Comparison between the two groups (M type cells vs E type cells) and statistical differences in mean values (DCT) were determined by a one-tailed t-test (P-value <0.1) using Excel software (Microsoft, Redmond, WA, USA). Statistical differences between the two groups (IC specimens with Hunner's lesion vs without Hunner's lesion) were determined by a twotailed t-test (P-value <0.05) using Excel. Multivariate analyses for IC specimens were carried out using SPSS software (IBM, Armonk, NY, USA). We used "principal axis factoring" as an extraction method, and "promax with Kaiser normalization" as a rotation method (Appendix S1). Initial extraction decreased the dimension down to six, but we found that the fifth and sixth axes were less relevant because of smaller eigenvalues (Appendix S1) and lower correlation with other factors. In contrast, we carried out "principal component analysis" with an extraction method "promax with Kaiser normalization." E-type cell lines were added to the analysis to estimate the distance between urothelial dysplasia and IC specimens. A total of 27 variables were chosen to segregate specimens between Hunner's lesion and "apparently normal" (Appendix S2).
Results mRNA expression of the 28 candidate TFs, as well as known urothelial marker genes, were measured in IC specimens sampled endoscopically (for all the Log 2 expression data, see Tables S3,S4 ). IC biopsies included various clinical status, including ulcerative-type biopsies (Hunner's lesion or an "apparently normal" urothelium counterpart from the same patient) and non-ulcerative type biopsies (urothelium with or without glomerulation during hydrodistension; Tables S3,S4) . Initially, we noted that E-cadherin expression (encoded by the CDH1 gene) had a huge variation among different IC specimens (Fig. 1a , Log 2 expression range: from 5.29 to 14.96, 815-fold expression difference). Endoscopic handling could have resulted in significant variation of the epithelial/ stromal ratio, and we presumed that the contaminated stroma (i.e. submucosal tissue and inflammatory cells) significantly affected data interpretation. Therefore, we changed the internal control of RT-PCR from 18s ribosomal RNA to CDH1 (Fig. 1a) , thereby exclusively focusing on urothelial status. UPK1A expression (uroplakin 1A, a known marker of urothelial cells) was lower in IC biopsies from Hunner's lesion (ulcer positive) compared with urothelium from both ulcerative and non-ulcerative patients (collectively defined as ulcer negative; Fig. 1b) . Furthermore, expression of other urothelial marker genes, TP63 (Fig. 2a) , SHH (Fig. 2b) or FOXA1 (data not shown, P = 0.035) was lower in Hunner's lesion. Conversely, RA receptor RARA expression was higher in ulcerpositive compared with ulcer-negative urothelium (Fig. 2c) . Among 28 candidate TFs, expression of EVX1 (Fig. 3a) , OVOL1 (Fig. 3a) , EHF (Fig. 3a) , ELF3 (data not shown, P = 0.046) or GRHL2 (data not shown, P = 0.033) was lower in Hunner's lesion. Conversely, expression of vitamin D receptor VDR (Fig. 3b), ELF4 (Fig. 3b) , IRF1 (Fig. 3b) , ETS2 (data not shown, P = 0.026), NR4A2 (data not shown, P = 0.012) or ZBTB7B (data not shown, P = 0.019) was higher in ulcer-positive compared with ulcernegative urothelium. In order to grasp the entire profile, Pearson's correlations among expression levels of known urothelial markers or candidate TFs are described in Table S5 . We noted that several factors are associated with each other, and the multivariate expression data could be decomposed to fewer numbers of dimensions. Factor analysis reduced the expression complexity of known urothelial markers and the candidate TFs, and we chose four axes for convenience of classification (Fig. 4 and Appendix S1). From the known markers, RA receptors RARA and RXRA were classified into the first axis (PA1; Fig. 4a) , and the second axis (PA2) was related to the urothelial basal cell marker, KRT5 (Fig. 4a) . Other known markers, KRT7, UPK1B and UPK3A were classified into PA2, but these three were inversely correlated with KRT5 (Fig. 4b) . The third axis (PA3) included four markers, TP63, KRT20, UPK1A and UPK3B (Fig. 4a) , which are closely associated with each other (Fig. 4b) . The fourth axis (PA4) included SHH and FOXA2 (Fig. 4a) . Most candidate TFs were classified according to these criteria, but some were underdetected (KLF3, KLF15, NR5A2 and FOS) in IC biopsies, and EHF and CEBPG were not classified into the four PAs, because of the poor correlation with other factors (Fig. 4a) . Finally, we sought to characterize IC biopsies according to these multivariate expression profiles (Fig. 5) . We added the expression dataset of E-type cell lines (initial screening materials), and carried out a PC analysis (Appendix S2). We drew a scatter plot, as shown in Figure 5 , according to three principal components. Although there was no remarkable segregation between ulcer statuses (black circles: Hunner's lesion, white circles: "apparently normal" urothelium counterparts from ulcerative type patients and urothelium from non-ulcerative type patients), biopsies from Hunner's lesion (black) tended to be located in particular PC areas (see Discussion; Fig. 5 ).
Discussion
According to the National Institute of Diabetes and Digestive and Kidney Diseases criteria, IC patients have either Hunner's lesion (ulcerative type) or glomerulation after hydrodistension (non-ulcerative type), but the boundary between them is sometimes obscure. 1 Importantly, the visible ulcer status does not necessarily reflect pain severity and relapse rate. 20 In contrast, the "apparently normal" urothelial counterpart of ulcerative IC patients could be "pre-malignant," making the prognostic prediction even more difficult. Therefore, it is critical to define the molecular pathology of intractable disease.
Several groups have reported comprehensive gene expression analyses for IC specimens using microarray. [21] [22] [23] Overall, Hunner's lesion shows an inflammatory signature, but the intrinsic abnormalities in urothelial homeostasis remain unclear. Erickson et al. showed that patient-derived urothelial cells display normal differentiation capacity in vitro. 24 Nevertheless, inflammatory cells and urothelium mutually interact, and the intrinsic alteration of urothelium in situ remains a pertinent question. In the present study, we purified mRNA from bladder biopsies sampled endoscopically from IC patients, and measured known urothelial marker gene expression levels and newly identified candidate urothelial master TFs. However, our attempt was hindered by the huge variability in CDH1 (E-cadherin) expression (Fig. 1a) . Practically, it is difficult to keep the ratio of epithelial-tomesenchymal tissues in the same range during the biopsy procedure (see Methods). Mesenchymal tissue including inflammatory cells could contribute to "mesenchymal noise" against authentic "urothelial signal." To troubleshoot this problem, we switched the normalization gene (internal control) from 18S rRNA to CDH1 (Fig. 1a) . Although the validity of this normalization should be scrutinized, more genes showed altered expression in Hunner's lesion under E-cadherin normalization (Figs 1-3) , suggesting that the improved detection could be a consequence of the modified methodology. Furthermore, the multivariate data were well correlated with each other (Table S3) , which prompted further analysis.
Bladder urothelium is organized into three layers, basal, intermediate and superficial layers. 19, 25 The superficial layer is covered by umbrella cells, which are terminally differentiated cells specialized for mechanical extension (also termed as transition epithelium). During tissue injury and regeneration, urothelial progenitor cells inside the intermediate layer actively proliferate and replenish the umbrella cells. 19 We decomposed multivariate expression data into four PAs, and found that the four PAs reflect the known urothelial biology (Fig. 4) . PA1 included RA receptor RARA and RXRA. RA is a critical signal for urothelial development and regeneration. 19 Mice treated with cyclophosphamide display rapid peel-off of the urothelium, which regenerates after the damage. The RA signal is activated during such experimental conditions. 19 RARA expression was higher in Hunner's lesion (Fig. 2c) , indicating that the urothelium could be undergoing regeneration. PA2 included KRT5, KRT7, UPK1B and UPK3A, but KRT5 showed an inverse correlation with the other three (Appendix S1). KRT5 is a marker of the urothelial basal layer, whereas KRT7, UPK1B and UPK3A are markers for the intermediate or superficial layers. 19, 25 We interpreted that PA2 reflects the layer localization inside the urothelium. 25 U PA3 included TP63, KRT20, UPK1A and UPK3B, whereas PA4 included SHH and FOXA2 (Appendix S1). TP63, SHH, and FOXA2 are endodermal markers and critical regulators for urothelial development. 25 TP63 is a master TF in stratified epithelium, 12 and is localized at the basal and intermediate layers of the urothelium. 19, 25 Lineage-tracing analysis showed that TP63 starts its expression in the urothelial stem cells. 26 In contrast, SHH is an evolutionally conserved developmental regulator. Developing urothelium and bladder stroma interact with each other through SHH and WNT signals. 27 Shhexpressing cells play an important role in urothelial progenitors during regeneration in cyclophosphamide-treated mice. 19, 27 We subsequently chose the 27 gene expression profile to segregate the Hunner's lesion from ulcer-negative specimens in principal component analysis (Fig. 5) . We noted that the ELF3  EVX1  KRT20  UPK3B SHH  TP63  UPK1A   GRHL2   FOXA1   UPK1B   UPK3A   KRT5   PITX1   HES2   KLF4   FOXA2  KLF13  ELF2  VDR  MEIS1  YY1  ZBTB7A ETS2  IRF1   IKZF3 specimens from Hunner's lesion tended to be plotted in PC1 (RA) high , PC2 (SOX13) high and PC3 (TP63) low (Fig. 5) . Based on the interpretation of PA1 (RA) and PA3 (TP63) described above, the pathology of Hunner's lesion could be represented as having "augmented regeneration" and "decreased progenitors." Urothelial regeneration should be within the physiological range if the progenitor cell replenishment and RA-induced differentiation are coupled with each other. In terms of urothelial biology, Hunner's lesion could be explained as "a disrupted homeostasis due to overloaded regeneration." In future, we would like to obtain further evidence to strengthen our hypothesis.
Finally, we did not use the urothelial biopsies from healthy volunteers. To date, non-tumor counterpart tissue from bladder carcinoma patients has been used for "normal urothelial control," but we used E-type cancer cell lines for the initial screening. Such cell lines retain physiological urothelial characters (see Methods), and gene expression profile is close to IC specimens to some extent (Fig. 5c) . In the future, we would like to overcome such technical issues by using cultured urothelial cells differentiated from induced pluripotent stem cells.
In conclusion, candidate urothelial master TFs could serve as novel diagnostic markers and potentially explain the molecular pathology of IC. 
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